[Congressional Record Volume 161, Number 51 (Thursday, March 26, 2015)]
[Senate]
[Page S2080]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 1099. Mr. MORAN (for himself, Mrs. Murray, Mr. Alexander, Mr. 
Durbin, Mr. Graham, Mr. Markey, Ms. Collins, Mr. Coons, Mr. Johnson, 
Mr. Wicker, Mr. Casey, Mr. Burr, Mr. Brown, Mr. Isakson, Mr. Schumer, 
Mr. Roberts, Ms. Klobuchar, Mr. Cassidy, Mr. Peters, Mr. Kirk, Ms. 
Hirono, Ms. Ayotte, Mr. Reed, Mr. Toomey, Mr. Franken, Mr. Hatch, Mr. 
Whitehouse, Mr. Gardner, Ms. Cantwell, Mr. Blunt, Mr. Booker, Mr. King, 
Mr. Merkley, Ms. Baldwin, and Mr. Blumenthal) proposed an amendment to 
the concurrent resolution S. Con. Res. 11, setting forth the 
congressional budget for the United States Government for fiscal year 
2016 and setting forth the appropriate budgetary levels for fiscal 
years 2017 through 2025; as follows:

       At the appropriate place, insert the following:

     SEC. ___. DEFICIT-NEUTRAL RESERVE FUND TO PROMOTE BIOMEDICAL 
                   RESEARCH.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution 
     for one or more bills, joint resolutions, amendments, 
     amendments between the Houses, motions, or conference reports 
     relating to Federal investments in precision medicine and 
     biomedical research, which may include increasing funding to 
     account for inflation, to support finding ways to prevent, 
     treat, and cure diseases or conditions like Alzheimer's and 
     other life-threatening or chronic illnesses, and to provide 
     long-term cost savings to the Federal Government, by the 
     amounts provided in such legislation for those purposes, 
     provided that such legislation would not increase the deficit 
     over either the period of the total of fiscal years 2016 
     through 2020 or the period of the total of fiscal years 2016 
     through 2025.
                                 ______